Liquid Biopsy Tests for Cancer
About this episode
This episode discusses the role of liquid biopsy tests in cancer management with expert insights from Ben Ho Park.
Circulating tumor DNA (ctDNA)(liquid biopsies) can help monitor cancer progression, detect residual cancer after treatment, and identify genetic changes within cancer cells that could affect treatment response. Author Ben Ho Park, MD, PhD, of the Vanderbilt-Ingram Cancer Center discusses current evidence regarding use of liquid biopsies in management of cancer with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content: Liquid Biopsies for Cancer Applications of Liquid Biopsy for Surgical Patients With Cancer
More episodes of JAMA Clinical Reviews
- Rheumatoid Arthritis
- An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)
- Medication Treatments for Alcohol Use Disorder
- Patient-Clinician Communication About Physical Activity
- Classic Hodgkin Lymphoma
- The Sleep-Weight Connection
Explore listener stats, chart rankings, contacts and more on the JAMA Clinical Reviews podcast page.